📰 Cell Squeeze News
Cell Squeeze News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Squeeze. Real-time updates on events, politics, business and more.
November 9, 2023
SQZ® AAC Phase 1 Trial Observed Best Overall Response (BOR) of Stable Disease or Better in 60 Percent (3 of 5) of Treated Patients, Including One Patient with a Confirmed Complete ResponseSQZ® eAPC Phase 1/2 Trial Monotherapy Observed BOR of Stable Disease in 40 Percent (8 of 20) of Treated PatientsReduced Workforce...
November 4, 2023
03.11.2023 - SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, presented clinical data for three programs focused on the treatment of Human Papillomavirus 16 positive (HB16+) driven cancers at the Society for ... Seite 1
August 11, 2023
Phase 1 SQZ-AAC-HPV-101 Clinical Trial Observed a Confirmed Complete Response in the First Patient and a Best Overall Response of Stable Disease in Two Additional Patients in the Lowest-Dose Cohort; Anticipate Interim Data in the Fourth Quarter of 2023SQZ® eAPC Phase 1/2 Trial Monotherapy Enrollment Complete; Antici...
July 25, 2023
WATERTOWN, Mass.--(BUSINESS WIRE)--Jul 25, 2023--
June 15, 2023
Company Received Notice Regarding NYSE Continued Listing Standards Section 802.01B ... | June 15, 2023
May 11, 2023
Phase 1 SQZ-AAC-HPV-101 Clinical Trial Resumed Following the Observation of a Confirmed Complete Response in the First Patient in the Lowest-Dose Cohort; Anticipate Data for the Highest-Dose Cohort in the Fourth Quarter of 2023SQZ® eAPC Phase 1/2 Trial Enrollment on Track; Anticipate Data for the Highest-Dose Monoth...
May 10, 2023
Phase 1 SQZ-AAC-HPV-101 Clinical Trial Resumed Following the Observation of a Confirmed Complete Response in the First Patient in the Lowest-Dose Cohort; Anticipate Data for the Highest-Dose Cohort... | June 15, 2023
March 12, 2023
Over the past ten years, an increase in head and neck malignancies has been related to human papillomavirus (HPV)
March 6, 2023
Research involving a cell "squeezing" process has shown promising results in a trial for the treatment of a subtype of HPV16-driven head and neck cancer.
March 6, 2023
Human papillomavirus (HPV) has been linked to a rising number of head and neck cancers over the past ten years. For instance, research indicates that HPV is responsible for 70 per cent of oropharyngeal cancer cases in the US.